Edwards announces positive results for Evoque valve replacem

Edwards Lifesciences (NYSE:EW) announced that one-year results from the TRISCEND study demonstrated favorable outcomes.

Related Keywords

London , City Of , United Kingdom , France , Didier Tchetche , Edwards Evoque , Clinique Pasteur , Bernardj Zovighian , ,